ALX Oncology Holdings Inc.
ALXO
$0.55
-$0.01-1.79%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 16.14% | -3.50% | -31.50% | -28.71% | -30.23% |
| Total Depreciation and Amortization | 4.31% | 17.85% | 27.01% | 68.41% | 144.44% |
| Total Amortization of Deferred Charges | 6.00% | 13.04% | 53.89% | 140.95% | 468.18% |
| Total Other Non-Cash Items | 15.07% | 9.38% | 1.77% | -9.25% | -12.34% |
| Change in Net Operating Assets | -249.81% | -127.97% | 403.00% | -62.62% | -15.77% |
| Cash from Operations | 6.48% | -16.34% | -21.83% | -45.77% | -46.11% |
| Capital Expenditure | 64.91% | 64.69% | 130.47% | 52.09% | 10.72% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 88.77% | -49.93% | -70.31% | 485.39% | 119.63% |
| Cash from Investing | 93.15% | -49.62% | -67.83% | 413.42% | 118.97% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -113.14% | -88.43% | -22.73% | -16.92% | 0.00% |
| Issuance of Common Stock | -50.72% | 13,378.75% | 13,283.97% | 8,857.66% | 6,996.23% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 774.11% | 3,901.83% | -709.16% | -110.08% | -571.76% |
| Cash from Financing | -48.02% | 832.06% | 830.72% | 545.96% | 501.33% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 81.68% | 88.18% | 20.59% | 48.74% | 91.61% |